IF by specialty › Hematology
Cytotherapy — Impact Factor
The 2025 Impact Factor of Cytotherapy is 4.5 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 4.5 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Elsevier (ISCT)
- Open access
- subscription or hybrid
- IF source
- sciencedirect.com
Position within the field
Ranked 22 of the 38 journals in Hematology on this site (bottom 50%).
Hematology journals with a similar Impact Factor
- Stem Cells IF 4.8
- Journal of Cerebral Blood Flow and Metabolism IF 4.7
- Transplantation and Cellular Therapy IF 4.7
- Seminars in Hematology IF 4.3
- Seminars in Thrombosis and Hemostasis IF 4.2
- Clinical Lymphoma Myeloma and Leukemia IF 4.1
About this value
The Journal Impact Factor of Cytotherapy (JCR 2025, released June 2026) is 4.5. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.